TimeMagazine

View original article Contributor: Megan Sarnacki

Chances are, you already know someone who’s an avid pickleball player. America’s fastest-growing sport—a cross between tennis, badminton, and ping-pong—can be played as either a singles or doubles game, though doubles is typically more popular. Points can only be accrued by the side that’s serving, and the winner is the first side to get to … Read more

While green tea has a long-standing reputation for health benefits, research has been much more mixed on black tea. One problem, says Maki Inoue-Choi, an epidemiologist at the National Cancer Institute, is that large observational studies on tea and mortality have focused on countries like Japan or China—places where green tea is more popular. To … Read more

High blood pressure—also known as hypertension—and Type 2 diabetes are two of the most common medical conditions in the U.S. Unfortunately, they often occur together. Some research has found that 85% of middle-aged or older adults who have Type 2 diabetes also have hyper­tension, and both conditions elevate a person’s risk for heart disease, stroke, … Read more

Derrick Morton was skeptical about working for Kaiser Permanente’s Bernard J. Tyson School of Medicine. The Pasadena, Calif., school hadn’t yet opened to students when he was offered a job in early 2020, and it felt risky to work for such a new institution. But Morton, who is Black, was eventually sold by the medical … Read more

Out-of-body and other mystical experiences can be life-changing, and research suggests they can even make people less afraid of dying. But such experiences are rare, and tend to occur accidentally and in the most extreme circumstances—such as at the brink of death. There might be another way to mimic the near-death experience: scientists have identified … Read more

COVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine. Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed several years ago protecting the technology behind its preventive shot, Spikevax. The company filed … Read more

With nearly all the new COVID-19 infections in the U.S. coming from the Omicron BA.4 and BA.5 subvariants, it makes sense that health officials are considering switching to a different vaccine to protect the public. White House COVID-19 response coordinator Dr. Ashish Jha expects the first Omicron-specific booster to be available in mid-September at the … Read more

GENEVA — The number of monkeypox cases reported globally dropped by 21% in the last week, reversing a month-long trend of rising infections and a possible signal the outbreak in Europe may be starting to decline, according to a World Health Organization report issued Thursday. The U.N. health agency reported 5,907 new weekly cases and … Read more

Back in March, people 50 and over—and younger people with weakened immune systems—became eligible to receive a second booster shot. If you got your second booster recently, can you still get the new Omicron-specific booster that health officials are expecting in September or October? The answer is yes. The U.S. Food and Drug Administration (FDA) … Read more